Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 541-560
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
 Philip Sawyer Investor at Bering Capital | San Francisco, United States | Venture capital | Healthcare | ||
 Parul Joshi Investor at LVX | Bengaluru, India | Syndicate / Angel groupVenture capital | HealthcareSaaS | ||
 Jiarui Huang Fosun Pharma 复星医药 - Investment Director at Fosun Pharma | Shanghai, China | Corporate VC | AIHealthcare | ||
 Berna Corapci Investor at Domino Ventures | Istanbul, Turkey | Venture capital | AIClimate | ||
 Hou Sheng Poh Investor at Entrepreneurs First | Singapore | AcceleratorVenture capital | AIHardware | ||
 Adam Bnamrhar Venture Capital Analyst at Sanofi | Paris, France | Corporate VC | AIHealthcare | ||
 Francois Pictet Managing Partner at Pictet Group | Geneva, Switzerland | Fund of fundsPrivate equity | AIHealthcare | ||
 Priscilla Luckhurst Msf Angel Investor at NuFund Venture Group | San Diego, United States | Corporate VCSyndicate / Angel group | AIConsumer | ||
 Erik Oleveris Angel Investor at Lux Capital | Canada | Venture capital | AIClimate | ||
 Francois Auzerais Sr. Investor at Yale Ventures | New York City, United States | Accelerator | ClimateHealthcare | ||
 Peng Zhong Affiliated at K2vc | New York, United States | Venture capital | AIClimate | ||
 Ahmed Willis Investor at Ghr Foundation | Minneapolis, United States | Family Office | EducationHealthcare | ||
 Mary Kate Sackinsky Investor at Morgan Stanley | San Francisco, United States | Corporate VCPrivate equity | FinTechHardware | ||
 Abby Draeger Primary Investment Analyst at Morgan Stanley | New York, United States | Corporate VCPrivate equity | FinTechHardware | ||
 Rachel Sun Tech Investor, Seed & Venture at Hillhouse Investment | Beijing, China | Private equityVenture capital | AIClimate | ||
 Fábio Santos Affiliated at Alexion Pharmaceuticals | New York, United States | Corporate VC | Healthcare | ||
 Ted Huang Affiliated at Yfy Biotech Management Company | Kaohsiung City, Taiwan | Venture capital | Healthcare | ||
 Martina Sardelli Investor at Entrepreneurs First | United Kingdom | AcceleratorVenture capital | AIHardware | ||
 Xiang Fan Investor at Fosun Pharma | Pudong, China | Corporate VC | AIHealthcare | ||
 Sara Picó Affiliated at Debiopharm Group | Lausanne, Switzerland | Corporate VC | AIHealthcare |
Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal